Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 7 | 2022 | 89 | 2.040 |
Why?
|
| Gene Expression Profiling | 6 | 2023 | 139 | 1.770 |
Why?
|
| Transcriptome | 8 | 2023 | 87 | 1.480 |
Why?
|
| Proteome | 5 | 2023 | 41 | 1.470 |
Why?
|
| RNA, Messenger | 3 | 2022 | 310 | 1.350 |
Why?
|
| Alzheimer Disease | 12 | 2023 | 2109 | 1.270 |
Why?
|
| Algorithms | 3 | 2023 | 350 | 1.200 |
Why?
|
| Cognitive Dysfunction | 8 | 2023 | 1061 | 0.980 |
Why?
|
| Brain | 11 | 2023 | 1649 | 0.930 |
Why?
|
| Dementia | 3 | 2022 | 560 | 0.740 |
Why?
|
| Sjogren's Syndrome | 2 | 2020 | 5 | 0.730 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 23 | 0.650 |
Why?
|
| Histones | 1 | 2019 | 32 | 0.650 |
Why?
|
| Blood Proteins | 1 | 2018 | 19 | 0.600 |
Why?
|
| ErbB Receptors | 2 | 2010 | 54 | 0.590 |
Why?
|
| Methotrexate | 1 | 2018 | 38 | 0.590 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 85 | 0.560 |
Why?
|
| Immunophenotyping | 1 | 2017 | 31 | 0.560 |
Why?
|
| Epigenomics | 1 | 2017 | 19 | 0.550 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 23 | 0.550 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 29 | 0.550 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 280 | 0.500 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 259 | 0.480 |
Why?
|
| Models, Genetic | 1 | 2015 | 41 | 0.470 |
Why?
|
| Humans | 28 | 2023 | 27072 | 0.380 |
Why?
|
| Aged | 13 | 2023 | 8997 | 0.370 |
Why?
|
| Phosphoproteins | 1 | 2010 | 26 | 0.350 |
Why?
|
| Amyloid beta-Peptides | 5 | 2023 | 324 | 0.300 |
Why?
|
| Aged, 80 and over | 10 | 2023 | 4777 | 0.300 |
Why?
|
| Models, Biological | 2 | 2010 | 322 | 0.290 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 155 | 0.290 |
Why?
|
| Mass Spectrometry | 2 | 2022 | 35 | 0.280 |
Why?
|
| Male | 15 | 2023 | 14772 | 0.270 |
Why?
|
| Cognition | 5 | 2023 | 1339 | 0.250 |
Why?
|
| Prefrontal Cortex | 3 | 2023 | 136 | 0.250 |
Why?
|
| Female | 13 | 2023 | 15212 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 381 | 0.230 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 46 | 0.230 |
Why?
|
| Cluster Analysis | 1 | 2023 | 47 | 0.220 |
Why?
|
| Benchmarking | 1 | 2023 | 32 | 0.210 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2023 | 3 | 0.210 |
Why?
|
| Phosphorylation | 4 | 2017 | 149 | 0.200 |
Why?
|
| Neurofibrillary Tangles | 2 | 2023 | 193 | 0.200 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 16 | 0.190 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 7 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 117 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 18 | 0.180 |
Why?
|
| Schizophrenia | 2 | 2011 | 62 | 0.180 |
Why?
|
| Movement Disorders | 1 | 2021 | 66 | 0.180 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2020 | 3 | 0.170 |
Why?
|
| Peptides | 1 | 2021 | 102 | 0.170 |
Why?
|
| Proteins | 1 | 2020 | 65 | 0.170 |
Why?
|
| tau Proteins | 4 | 2023 | 232 | 0.170 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 271 | 0.170 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 205 | 0.160 |
Why?
|
| Acetylation | 1 | 2019 | 14 | 0.160 |
Why?
|
| Parkinsonian Disorders | 1 | 2023 | 225 | 0.160 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 175 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 26 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2019 | 46 | 0.160 |
Why?
|
| Pyrimidines | 2 | 2017 | 21 | 0.160 |
Why?
|
| Sleep Deprivation | 1 | 2019 | 73 | 0.150 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 3 | 0.150 |
Why?
|
| Seasons | 1 | 2018 | 22 | 0.150 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 1196 | 0.150 |
Why?
|
| Infliximab | 1 | 2018 | 17 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.150 |
Why?
|
| Up-Regulation | 1 | 2019 | 170 | 0.150 |
Why?
|
| Cell Count | 1 | 2018 | 81 | 0.150 |
Why?
|
| Genotype | 1 | 2019 | 346 | 0.150 |
Why?
|
| Remission Induction | 1 | 2018 | 90 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2018 | 58 | 0.150 |
Why?
|
| Monocytes | 1 | 2018 | 61 | 0.150 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 111 | 0.140 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 85 | 0.140 |
Why?
|
| Neutrophils | 1 | 2018 | 104 | 0.140 |
Why?
|
| Independent Living | 1 | 2020 | 322 | 0.140 |
Why?
|
| Phenotype | 3 | 2023 | 312 | 0.140 |
Why?
|
| Computational Biology | 1 | 2017 | 21 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 15 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2017 | 22 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2010 | 195 | 0.140 |
Why?
|
| ADAM Proteins | 1 | 2017 | 40 | 0.140 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 24 | 0.140 |
Why?
|
| Motor Activity | 1 | 2019 | 323 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 53 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2018 | 587 | 0.130 |
Why?
|
| Imidazoles | 1 | 2017 | 59 | 0.130 |
Why?
|
| Chicago | 1 | 2019 | 949 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 111 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2010 | 443 | 0.130 |
Why?
|
| Parkinson Disease | 1 | 2023 | 670 | 0.130 |
Why?
|
| Gene Expression | 3 | 2023 | 199 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1368 | 0.120 |
Why?
|
| Markov Chains | 1 | 2015 | 33 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 879 | 0.120 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 50 | 0.120 |
Why?
|
| Bayes Theorem | 1 | 2015 | 42 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 57 | 0.110 |
Why?
|
| Epidermal Growth Factor | 2 | 2010 | 27 | 0.110 |
Why?
|
| Risk Factors | 1 | 2019 | 2302 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2019 | 985 | 0.100 |
Why?
|
| Aging | 2 | 2019 | 1544 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2023 | 43 | 0.100 |
Why?
|
| Adult | 3 | 2023 | 7831 | 0.090 |
Why?
|
| Tyrosine | 1 | 2010 | 23 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 23 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 23 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 7 | 0.090 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Diseases in Twins | 1 | 2010 | 9 | 0.090 |
Why?
|
| Middle Aged | 4 | 2018 | 8923 | 0.090 |
Why?
|
| Linear Models | 2 | 2023 | 247 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2010 | 147 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 278 | 0.090 |
Why?
|
| Cell Line | 1 | 2010 | 273 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3485 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2019 | 1890 | 0.080 |
Why?
|
| Mutation | 1 | 2010 | 348 | 0.080 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 1 | 0.080 |
Why?
|
| Animals | 2 | 2019 | 3642 | 0.070 |
Why?
|
| Autopsy | 2 | 2019 | 344 | 0.070 |
Why?
|
| Neurons | 2 | 2021 | 339 | 0.070 |
Why?
|
| Computer Graphics | 1 | 2006 | 4 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 154 | 0.060 |
Why?
|
| Software | 1 | 2006 | 61 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 188 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2023 | 11 | 0.050 |
Why?
|
| Base Sequence | 1 | 2023 | 109 | 0.050 |
Why?
|
| DNA | 1 | 2023 | 106 | 0.050 |
Why?
|
| Organ Size | 1 | 2023 | 95 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2023 | 13 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2023 | 9 | 0.050 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 2023 | 7 | 0.050 |
Why?
|
| Adaptor Protein Complex beta Subunits | 1 | 2023 | 7 | 0.050 |
Why?
|
| Mitochondria | 1 | 2023 | 67 | 0.050 |
Why?
|
| RNA | 1 | 2023 | 37 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2023 | 38 | 0.050 |
Why?
|
| Neuropathology | 1 | 2023 | 81 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 65 | 0.050 |
Why?
|
| Alleles | 1 | 2021 | 216 | 0.050 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2020 | 5 | 0.040 |
Why?
|
| Actinin | 1 | 2020 | 7 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 10 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 18 | 0.040 |
Why?
|
| Epoxide Hydrolases | 1 | 2020 | 11 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 13 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 49 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2020 | 27 | 0.040 |
Why?
|
| Germinal Center | 1 | 2020 | 1 | 0.040 |
Why?
|
| SOXC Transcription Factors | 1 | 2020 | 1 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 42 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 64 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 56 | 0.040 |
Why?
|
| Thy-1 Antigens | 1 | 2019 | 1 | 0.040 |
Why?
|
| Sensory Gating | 1 | 2019 | 3 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 10 | 0.040 |
Why?
|
| Schizophrenic Psychology | 1 | 2019 | 14 | 0.040 |
Why?
|
| Nerve Net | 1 | 2019 | 40 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 66 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 93 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 219 | 0.040 |
Why?
|
| Microglia | 1 | 2019 | 143 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 126 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 145 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 12 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 366 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 78 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 123 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 116 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 83 | 0.040 |
Why?
|
| Memory | 1 | 2019 | 297 | 0.040 |
Why?
|
| Lewy Bodies | 1 | 2019 | 192 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 161 | 0.040 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 112 | 0.040 |
Why?
|
| Logistic Models | 1 | 2018 | 395 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 12 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 2019 | 263 | 0.030 |
Why?
|
| Hippocampus | 1 | 2019 | 273 | 0.030 |
Why?
|
| Exons | 1 | 2017 | 33 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 37 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 81 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 107 | 0.030 |
Why?
|
| Genome, Human | 1 | 2017 | 50 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 328 | 0.030 |
Why?
|
| Astrocytes | 1 | 2018 | 144 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 347 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 599 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1778 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 562 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 891 | 0.030 |
Why?
|
| Mice | 1 | 2019 | 1395 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1112 | 0.030 |
Why?
|
| Coenzyme A Ligases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 20 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 19 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 120 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 83 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2008 | 7 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 256 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 1433 | 0.010 |
Why?
|